SEC Form 4
AETHLON MEDICAL INC (AEMD) insider trading
No open-market AEMD insider purchases or sales were filed in the 12 months to Oct 26, 2026.
Latest filing · Last 12 months · Source: SEC EDGAR · How we count
- Open-market sales
- $0
- 0 filings · 0 insiders
- Open-market purchases
- $0
- 0 filings
Who traded AEMD, and when
AEMD daily close from Oct 27, 2025 to Oct 26, 2026, between $1.43 and $28.75, last $5.15. No open-market insider purchases or sales were filed in this period.
No open-market insider purchases or sales were filed in the last 12 months.
Open-market trades
0 filings in the last 12 months| Insider | Role | Sold | Bought | Filings | Pre-arranged (10b5-1) | Last filed |
|---|---|---|---|---|---|---|
| No open-market purchases or sales in the last 12 months. | ||||||
| Filed | Insider | Type | Shares | Avg price | Value | Held after | Source |
|---|---|---|---|---|---|---|---|
| No open-market purchases or sales in the last 12 months. | |||||||
GET /stocks/filings/vX/form-4?tickers=AEMD&filing_date.gte=2025-10-26&sort=filing_date.desc&limit=500{
"status": "OK",
"results": [
{
"tickers": [
"AEMD"
],
"issuer_cik": "0000882291",
"owner_cik": "0001284599",
"accession_number": "0001683168-26-007878",
"form_type": "4",
"filing_date": "2026-10-15",
"period_of_report": "2026-09-30",
"issuer_name": "AETHLON MEDICAL INC",
"issuer_trading_symbol": "AEMD",
"owner_name": "BROENNIMAN EDWARD G",
"is_director": true,
"is_officer": false,
"is_ten_percent_owner": false,
"is_other": false,
"security_type": "non_derivative",
"record_type": "transaction",
"security_title": "Common Stock",
"transaction_timeliness": "O",
"aff_10b5_one": false,
"transaction_date": "2026-09-30",
"transaction_code": "F",
"equity_swap_involved": false,
"transaction_shares": 218,
"transaction_price_per_share": 6.52,
"transaction_acquired_disposed": "D",
"shares_owned_following_transaction": 4313,
"transaction_value": 1421.36,
"not_subject_to_section_16": false,
"direct_or_indirect": "D",
"footnotes": [
{
"id": "F1",
"description": "The Reporting Person forfeited 218 shares of common stock upon conversion of an aggregate 1,091 vested and outstanding restricted stock units into shares of common stock to cover tax withholdings, using the market price of the issuer's common stock at the time of forfeiture. These restricted stock units were part of the grant reported in Table I of the Form 4 filed by the Reporting Person with the Securities and Exchange Commission on April 17, 2026."
},
{
"id": "F2",
"description": "The amount of securities beneficially owned is being amended to account for a typographical error in the Form 4 filed on April 21, 2026. The number of shares beneficially owned following the reported transaction was shown as 23,454 shares, but should have been 23,730."
}
]
},
{
"tickers": [
"AEMD"
],
"issuer_cik": "0000882291",
"owner_cik": "0001566040",
"accession_number": "0001683168-26-007881",
"form_type": "4",
"filing_date": "2026-10-15",
"period_of_report": "2026-09-30",
"issuer_name": "AETHLON MEDICAL INC",
"issuer_trading_symbol": "AEMD",
"owner_name": "Shah Chetan",
"is_director": true,
"is_officer": false,
"is_ten_percent_owner": false,
"is_other": false,
"security_type": "non_derivative",
"record_type": "transaction",
"security_title": "Common Stock",
"transaction_timeliness": "O",
"aff_10b5_one": false,
"transaction_date": "2026-09-30",
"transaction_code": "F",
"equity_swap_involved": false,
"transaction_shares": 436,
"transaction_price_per_share": 6.52,
"transaction_acquired_disposed": "D",
"shares_owned_following_transaction": 3787,
"transaction_value": 2842.72,
"not_subject_to_section_16": false,
"direct_or_indirect": "D",
"footnotes": [
{
"id": "F1",
"description": "The Reporting Person forfeited 436 shares of common stock upon conversion of an aggregate 1,091 vested and outstanding restricted stock units into shares of common stock to cover tax withholdings, using the market price of the issuer's common stock at the time of forfeiture. These restricted stock units were part of the grant reported in Table I of the Form 4 filed by the Reporting Person with the Securities and Exchange Commission on April 17, 2026."
},
{
"id": "F2",
"description": "The amount of securities beneficially owned is being amended to account for a typographical error in the Form 4 filed on April 21, 2026. The number of shares beneficially owned following the reported transaction was shown as 23,021 shares, but should have been 23,278."
}
]
}
]
}
// trimmed to 2 resultsThe response includes every Form 4 record; this page keeps open-market purchases and sales on common stock and removes duplicate joint-filer rows.
Other insider activity (not market trades) · 18 records
- Tax withholding12 records
- Grants and awards6 records
Reported on Form 4 but not purchases or sales in the market, so not counted in the totals above.
How to read this page
- Open-market purchase or sale
- A buy or sell of the company's stock at market price. Grants, option exercises, shares withheld for tax, gifts and employee stock plan purchases are listed separately and not counted.
- Filing date
- Insiders have two business days to report a trade. Totals and the chart use the filing date, when the trade became public.
Frequently asked questions
Has AETHLON MEDICAL INC's CEO sold stock?
No. James B. Frakes (CEO) made no open-market sales filed as CEO in the last 12 months.
How current is AEMD’s insider data?
These are AEMD Form 4 filings from the last year, refreshed daily. The Massive Form 4 API has the full, continuously updated record.
What counts as an open-market buy or sell?
Only purchases and sales at the market price. Option exercises, grants, gifts, and shares withheld for taxes are reported on Form 4 but are left out of the buy and sell totals.
Build with AI
Track AEMD insider trades with your agent
This page joins two Massive endpoints: Form 4 filings and daily prices. Ask an agent to watch for new filings:
Using the Massive API (massive.com/docs/llms.txt), check Form 4 filings for AEMD every day with transaction_code=P and tell me when an insider files an open-market purchase, with their role, shares, price and the filing link.
Nothing on this page is investment advice. All data and content is provided for informational purposes under our Terms of Service.